Lundin Law PC announces a class action lawsuit has been filed against
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL)
concerning possible violations of federal securities laws between May
17, 2013 and December 28, 2015. Investors who purchased or otherwise
acquired shares during the Class Period should contact the Firm in
advance of the February 29, 2016, lead plaintiff motion deadline.
To
participate in this class action lawsuit, please contact Brian
Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via e-mail at brian@lundinlawpc.com.
According to the complaint, the Company failed to disclose that: (i)
Anavex had used a paid stock promoter to artificially inflate the
Company's share price; and (ii) as a result of the foregoing, Anavex's
public statements were materially false and misleading at all relevant
times.
No class has been certified in the above action. Until a class is
certified, you are not considered represented by an attorney. You may
also choose to do nothing and be an absent class member.
Lundin Law PC was created by Brian Lundin, a securities litigator based
in Los Angeles.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160217006745/en/
Copyright Business Wire 2016